This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked

peer-reviewed publication

trusted source

proofread

MAPLE: A phylogenetic tool for pandemic-scale genome data

MAPLE: a phylogenetic tool for pandemic-scale genome data
Phylogenetic tool for pandemic-scale genome data. Credit: Karen Arnott/EMBL-EBI

With the huge abundance of genomic data generated from life science experiments, processing large datasets remains a challenge in the field of bioinformatics. During the COVID-19 pandemic, the limited capabilities of existing bioinformatics tools meant that large amounts of data could not be analyzed all at once, limiting the scope of evolutionary and epidemiological analysis.

To address this problem, a team led by researchers at EMBL's European Bioinformatics Institute (EMBL-EBI) has developed a new tool that can handle large-scale genomic datasets, allowing scientists to analyze millions of viral genomes all at once.

This research, published in the journal Nature Genetics, describes a new method—MAximum Parsimonious Likelihood Estimation (MAPLE)—that uses new mathematical approximations to develop an algorithm that works specifically on closely related genomes. This new approach enables rapid reconstruction of phylogenetic trees—a crucial step for understanding viral evolution and epidemiological spread.

Lessons learned from the pandemic

During the COVID-19 pandemic, researchers struggled to analyze the large number of genomic datasets generated. This made it challenging to study how the SARS-CoV-2 virus was evolving and spreading. Limitations of standard bioinformatic tools forced researchers to focus only on a small subset of samples at the time. Researchers everywhere soon realized that they needed faster and more efficient methods.

"We faced many challenges for analyzing all the data that was coming in during the pandemic," said Nicola De Maio, Research Staff Scientist at EMBL-EBI. "Traditional phylogenetic tools became inadequate as the data volume increased. We worked with others to try to 'stretch' these methods. We tried using supercomputers to solve the problem, but at some point, nothing seemed to work anymore. This prompted us to create MAPLE."

The most significant advantage of MAPLE is its ability to process large-scale genomic data sets; millions of microbial genomes can be analyzed at once.

Tools for epidemiological problems

Often, the tools used for studying evolution are the same whether you are looking at recent outbreaks of viruses and bacteria or at the evolution of distantly related species. To speed up phylogenetic inference within genomic epidemiology, the researchers developed a new algorithm that worked better for closely related samples—for example, viral genomes with only dozens of nucleotide differences, as is the case for SARS-CoV-2 genomes.

The researchers also realized that the lessons learned during this pandemic will be useful for bioinformatics tools moving forward. To be prepared for future pandemics, bioinformatic tools must cope with even larger scales of data.

"We as bioinformaticians learned a lot from the COVID-19 , but we also need to think about the future and how we can be better prepared," said Nick Goldman, Group Leader at EMBL-EBI. "Bioinformatic tools need to be able to cope with more data, and we need tools for a range of specific tasks. New tools such as MAPLE can be a valuable addition to the bioinformatics community's arsenal, helping researchers to process viral data faster and more efficiently for evolutionary analysis."

More information: Nicola De Maio et al, Maximum likelihood pandemic-scale phylogenetics, Nature Genetics (2023). DOI: 10.1038/s41588-023-01368-0

Journal information: Nature Genetics
Citation: MAPLE: A phylogenetic tool for pandemic-scale genome data (2023, April 11) retrieved 19 June 2024 from https://medicalxpress.com/news/2023-04-maple-phylogenetic-tool-pandemic-scale-genome.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Evolutionary analysis shows SARS-CoV-2 variants converging

13 shares

Feedback to editors